CFS Clinical Chooses C3i Tech Support
CFS Clinical has selected C3i, a service desk support and business process outsourcing services provider.
CFS Clinical has selected C3i, a service desk support and business process outsourcing services provider. C3i is providing global 24x365 multilingual technology support services for CFS’ Site Activation and Investigator Payment Services. The service desk supports active clinical trial sites in nearly 50 countries and 12 languages, staffed out of C3i’s Sofia Operations Center. Additional languages will be added later this year, to manage CFS’ continued scaling, supported out of C3i’s Dalian Operations Center.
Read the full release here.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
